Eledon Pharmaceuticals, Inc. (ELDN)

NCM – Real Time Price. Currency in USD

3.69

-0.06 (-1.47%)

Market open: Aug 12, 2026, 1:27 PM EDT

3.73

-0.02 (-0.58%)

Previous after-hours: Aug 11, 2026, 7:34 PM EDT

Summary
News
Chart
Financial
Dividends
Forecast
Ownership
Profile

Revenue

Gross Profit

Operating Income

Net Income

Income Statement
Balance Sheet
Cash Flow

Income Statement (Annual)

Financials in millions USD. Fiscal year is January – December.

Name

2025

2024

2023

2022

Total Revenue

Cost of goods sold

-359K

-374K

-373K

Gross Profit

-359K

-374K

-373K

Operating expenses (excl. COGS)

-83M

-70M

-43M

-39M

Operating Income

-83M

-71M

-43M

-40M

Non-operating income, total

38M

35M

-74M

-48M

Pretax income

-46M

-36M

-117M

-88M

Equity in earnings

Taxes

-35K

-431K

Non-controlling/minority interest

After tax other income/expense

Net income before discontinued operations

-46M

-36M

-117M

-88M

Discontinued operations

Net income

-46M

-36M

-117M

-88M

Dilution adjustment

Preferred dividends

Eledon Pharmaceuticals, Inc. (ELDN)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Eledon Pharmaceuticals, Inc. (ELDN)

Income Statement (Annual)

Income Statement (Annual)

Search stocks

Eledon Pharmaceuticals, Inc. (ELDN)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Eledon Pharmaceuticals, Inc. (ELDN)

Income Statement (Annual)

Income Statement (Annual)